US Physical Therapy's stock surged 5.07% during intraday trading on Friday, showing significant upward momentum in the market.
The sharp rise follows a positive analyst report from Barrington, where Michael Petusky maintained a Buy rating on the company with a price target of $103.00. This bullish outlook from the analyst appears to have generated increased investor confidence and buying activity in the stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.